MNQ 0.00% 0.0¢ minquest limited

Agreed its not a battle between ePAT and RAP. They both should...

  1. Io
    582 Posts.
    lightbulb Created with Sketch. 34
    Agreed its not a battle between ePAT and RAP. They both should do well in an expanding market sector. For ePAT, RAP is a good path finder to show what is possible if you get it right and its a guide to potential market cap's. Watching how RAP go about their FDA approval will also be helpful for ePAT. Hopefully, ePAT get the benefit of being a fast follower albeit with a different product but in the same market sector.
 
watchlist Created with Sketch. Add MNQ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.